Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Farmers Insurance
Medtronic
Chubb
Teva
McKinsey

Generated: September 23, 2019

DrugPatentWatch Database Preview

Patent: 7,998,667

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,998,667
Title:Mutations of the parkin gene, compositions, methods and uses
Abstract: The invention concerns nucleic acids coding for mutated or truncated forms of the human parkin gene, or forms comprising multiplication of exons, and the corresponding proteins and antibodies. The invention also concerns methods and kits for identifying mutations of the parkin gene, and for studying compounds for therapeutic purposes.
Inventor(s): Brice; Alexis (Paris, FR), Lucking; Christophe (Paris, FR), Denefle; Patrice (Saint Maur, FR), Ricard; Sylvain (Paris, FR), Abbas; Nacer Eddine (Paris, FR), Bouley; Sandrine (Bletterans, FR)
Assignee: Aventis Pharma S.A. (Antony, FR) Institut National Sante et Recherche Medicale (Paris, FR)
Application Number:09/856,290
Patent Claims:see list of patent claims

Details for Patent 7,998,667

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04 ➤ Sign Up Aventis Pharma S.A. (Antony, FR) Institut National Sante et Recherche Medicale (Paris, FR) 2018-11-19 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04 ➤ Sign Up Aventis Pharma S.A. (Antony, FR) Institut National Sante et Recherche Medicale (Paris, FR) 2018-11-19 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04 ➤ Sign Up Aventis Pharma S.A. (Antony, FR) Institut National Sante et Recherche Medicale (Paris, FR) 2018-11-19 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Accenture
Citi
McKesson
Queensland Health
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.